Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00064974
Recruitment Status : Completed
First Posted : July 17, 2003
Last Update Posted : April 4, 2013
Information provided by (Responsible Party):
Celgene ( Celgene Corporation )